HAYWARD, Calif., June 29, 2017 /PRNewswire/ -- Impax Laboratories, Inc. (NASDAQ: IPXL) announced today thatthe Company will release its second quarter 2017 financial results on Wednesday, August 9, 2017, prior to the open of the U.S. financial markets. The Company will host a conference call and live webcast with the investment
The financial results and live webcast will be accessible through the Investor Relations section of the Company's Web site at http://investors.impaxlabs.com.
To access the call through a conference line, dial (877) 356-3814 (in the U.S.) and (706) 758-0033 (international callers). The conference ID is 48618927.
A replay of the conference call will be available for seven days shortly after the call. To access the replay, dial (855) 859-2056 (in the U.S.) and (404) 537-3406 (international callers). The access code for the replay is 48618927.
About Impax Laboratories, Inc.Impax Laboratories, Inc. (Impax) is a specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of central nervous system disorder branded products. Impax markets its generic products through its Impax Generics division and markets its branded products through the Impax Specialty Pharma division. Additionally, where strategically appropriate, Impax develops marketing partnerships to fully leverage its technology platform and pursues partnership opportunities that offer alternative dosage form technologies, such as injectables, nasal sprays, inhalers, patches, creams, and ointments.
For more information, visit Impax's website at: www.impaxlabs.com.
Contact:Mark DonohueInvestor Relations and Corporate Communications (215) 558-4526www.impaxlabs.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/impax-to-report-second-quarter-2017-results-on-august-9-2017-300481846.html
SOURCE Impax Laboratories, Inc.
Subscribe to our Free Newsletters!
Lazy eye or amblyopia occurs when sight in one eye is less than the other in early childhood due to ...
Tracheal or windpipe cancer is a rare cancer and its cause is unclear. The most common squamous ...
Tecovirimat can be used to treat smallpox disease in adult and pediatric patients who weigh at ...View All